Reprinted from THE .lonma~ OF 1"~aanr~cotoar AX~I EXPERIVEFTAL THEIIAP~U~ICS Vol. 107, No. 4, April, 1953 Printed in U.S. A THE FATE OF CAFFEINE IN MAN AND A METHOD FOR ITS ESTIMATIOX IN BIOLOGICAL MATERIAL JULIUS AXELROD AND JULES REICHEKTHAL' Laboratory of Chenlical Pharmacology, National Heart Institute, Nalional Institutes of Health, V. S. Public Health Service, Federal Security Agency, Bethesda, Maryland Received for publication November 24, 1952 Caffeine is extensively used as a therapeutic agent and is widely ingested in the form of cafleine contaiLing beverages, yet little is known concerning its fate in the body. The development of a simple and sensitive method for the estimation of caffeine in biologica. materials has permitted studies of its absorption, excre- tion, distribution and rate of biotransformation in man. CHE~IICAL METHOD. The estimation of cafeine. Older methods for the determination of car7eine in biological material involve extraction into chloroform, followed by assay of the drug by its nitrogen content (Kunz, 1935) or by a color-producing murexide re- action (Tanaka and Ohkubo, 1937). These methods are insensitive and inaccurate. Recently, Ishler et al. (1948) described a sensitive method, using ultraviolet spectrophotometry, for the estimation of caffeine in coffee preparations. This method was applied by Fisher et at. (1949) to the estimation of caffeine in urine. In this method caffeine is extracted from the biological material with chloroform, which also extracts other methyl xanthines and inter- fering normal constituents of biological materials. In the following procedure, caffeine is isolated from biological material at pH 7-8 by extraction into benzene. The compound is then returned to an aqueous phase by shaking with 5 N HCl and its absorption in the ultraviolet is measured at 273 rn+ The relativel? nonpolar solvent benzene was chosen as the solvent least likely to extract meta- bolic products of caffeine and normal constituents of urine according to principles previous described (Brodie ef al., 1947). The ext,racticn is augmented by saturating the aqueous phase with sodium chloride. A small amount of interfering blank material in urine and tissues which is also extracted into benzene is almost entirely removed by shaking the solvent extract with dilute XaOH. Since caffeine is basic it can be extracted from the ben- zene phase into 5 X HCl. This effectively separates it from methytated xanthines such as theobromine and theophylline. Procedure for plasma. Pipet 1 to 5 ml. of plasma into a 60 ml. glass-stoppered bottle con- taining 40 ml. of benzene* and about 3 gm. of sodium chloride. &ske for 20 minutes. Centri- fuge the bottle and pipet 30 ml. of the benzene phase int,o a 60 ml. glass-stoppered bottle' containing4 ml. of 5 N HCl. Sh&e for 5 minutes, transfer 3 ml. of the acid phase to a quarhz cuvct. Determine the optical density at 273 mp in a Beckman DU spectrophotometer.' 1 Part, of the mar,erinl in this paper was taken from a thesis submitted to the Chemistry Department of thq Graduate Sjchool of Ceorgectown University, in partial fulfillment of the requirements for the degree of bIss!er of Science. * Benzene, reagent grade, is purified by successive washings with >C volume of 1 N NaOH, 1 N HCl, and twice with watt>r. * Glassware used in this and subsequent steps in the chemical procedure is immersed in 5 N I-ICI for 2 hours and thoroughly rinsed witl%stilled water. The quartz cuvets are similarly treat,ed. 4 The optical density reading of 5 N HCl in a quartz cuvct siowiy increases wit.h t,ime. To minimize this potential error, the optical density readings &ould be measured within a few minutes after the extraction of the caffeine into the acid phase. 519 520 JULIUS AXELROD AND JULES REICHENTHAL The instrument is set at 100 per cent transmission wit,h distilled water. An optical density of about 0.200 is obtained when 25 microgm. of caffeine are assayed by this procedure. Standards are prepared by dilution of a st,ock caffeine solution with 5 N HCl. Urilre and tissues. Pipet 3 ml. of urine or tissue homogenate: adjusted to pH 7-8, into a 60 ml. glass-stoppered bottle containing 40 ml. of benzene and about 3 gm. of sodium chlo- ride. Shake for 20 minutes. Centrifuge the bottle and transfer as much of the benzene phase as possible to a 60 ml. gla&-stoppmed bottle containing 3 ml. of 0.1 N SaOH saturated with sodium chloride. Shake for 5 minutes and centrifuge. Pipet. 30 ml. of the benzene phase into a 60 ml. glass-stoppered bottle containing.4 ml. of 5 N HCl and continue as described for the estimation of caffeine in plasma. Caffeine added to biological material in amounts from 5 to 50 microgm. were recovered with adequate precision (98 f 3 per cent). Appruisal oj specificity. There is a small blank equivalent to 0.1-0.5 mierogm. of caffeine per ml. of normal plasma and 0.5 to 2.0 microgm. per ml. of urine or per gram of organ tissue. The possible interference of metabolic products of the drug in the plasma procedure was ex- TABLE 1 Distribution of caffeine and apparent cafleine between water and various benzene-petroleum ether mixtures The apparent caffeine from the pooled plasma of two subjects receiving caffeine was extracted int,o benzene as described under the chemical method. The drug was returned to 5 N HCl. The acid ext.ract was adjusted with NaOH to pH 7. Aliquots of this solution and of an authentic solut,ipn of caffeine similarly adjusted to pH 7 were shaken with 4 volumes of the various benzene petroleum ether mixtures. The distribution is expressed' as the ratio of the amount of compound in the organic phase to total compound. 0.89 0.92 0.81 0.84 0.60 0.62 0.45 0.46 0.27 0.27 amined by the technique of comparative distribution ratios (Brodie et al., 1947). Plasma was obtained two hours after 7 mgm. per kgm. of caffeine was administered intravenously to two human subjects. The apparent caffeine was extracted from the pooled plasma in the same manner as described in the procedure. The distribution ratios of the apparent caffeine pi'ere compared with those of authentic caffeine in a series of two phase systems consisting of water at pH 7 and benzene and petroleum ether in various proportions. The results indi- cate that the two substances possess the same solubility characteristics and were presumably the same compound (table 1). EXPERIMENTAL. Lirinar2/ ezcrdion of cufleine. Three ma.le subjects each re- ceived 500 mgm. of caffeine6 intravenously and urine was collected for the sub- sequent 24 hours. Only 0.5 to 1.5 per cent of the administered caffeine was excreted unchanged, indicating that the drug had undergone almost complete transformation in the body. 1 Organ tissues are prepared fir analysis by emulsification in water as described in a previous paper (Brodie el al., 1947). 6 The caffeine was administered in this and in subsequent esperiments as caffeine-sodium benzoate. FATE OF CAFFEISE IN MAN 521 Absorption of caffeine. Information was obtained concerning the part played by absorption from the gastrointestinal tract in the physiological disposition of caffeine. Plasma levels of the drug were compared after oral and intravenous administration of 7 mgm. per kgm. of caffeine in three male subjects. After oral administration, peak plasma levels of about 10 mgm. per liter occurred in about one hour after which the levels closely approximated t.hose following the intra- venous administration (fig. 1). Absorption from the gastrointestinal tract is thus rapid and essentially complete. DisMndion of caffei?le ,in tissues. The extent to which caffeine in plasma is bound to proteins was determined by dialysis at 37oC. for 18 hours t,hrough FIG. 1. Plasma levels of caffeine after the oral (solid line) and intravenous (dashed line) administration of 7 mgm. per kgm. of caffeine to three subjects. Visking membranes against isotonic phosphate buffer at pl? 7.4. In these experi- ments the drug was added directly to plasma. At plasma levels ranging from 9 to 45 mgm. per,liter, about 15 per cent of the caffeine was found to be bound to the non-diffusible constituents of the plasma. The distribut,ion of caffeine was examined in representat.ive tissues of a dog 3 hours after the intraperitoneal injection of 84 mgm. per kbm. of the drug. The animal was sacrificed by an intravenous injection of air and t.he tissues were sampled immediately afterwards. Tissue water was determined by drying to constant weight at 95-100oC. The tissue concentration of caffeine was measured and calculated in terms of tissue water. The caffeine concentration in the water of various tissues was found to be nearly the same as that in plasma water (table 2), indicating that the drug is distributed in tissues in approximate proportion to their water content. The concentration.of caffeine in cerebrospinal fluid was 522 JULIUS -4XELROD AND JULES REICHENTH.4L found to be almost the same as that in plasma mater, suggesting that there is little hindrance to the passage of the drug across the blood-brain barrier. The rate of disappearance of intravenously administered cafleine from plasma, Twelve male subjects mere given 7 mgm. per kgm. of caffeine, administered intra- venously, .and the drug plasma levels were measured at various time intervals. In all cases the logarithm of &he plasma concentration when plotted a.gainst TABLE 2 The distribution of cafeine in dog The dog received 84 mgm. per kgm. of caffeine intravenously. The tissues were examined 3 hours after the administration of the drug. Plasma ............................... Red blood cells. ..................... Cerebrospinal fluid. .................. Liver ................................. Lung ................................. Heart ................................ Muscle ............................... Kidney ............................... Spleen .............................. Brain ................................. 82.7 1.0 83.0 1.0 78.2 0.95 91.7 1.11 71.5 0.87 77.0 0.93 71.0 0.88 82.1 0.99 73.2 0.89 77.2 0.93 TABLE 3 Plasma levels of caffeine after co$ee drinking Two cups of coffee taken at 8:00 a.m., 12 noon, 3:OO p.m., and 6:00 p.m. Blood samples were drawn at 8:OO a.m. (Bo), 9:OO a.m. (B1), I:00 p.m. (Bi), 7:00 p.m. (Bs), and the follow- ing morning at 8:CKl a.m. (B,). No caffeine containing beverages were taken 24 hours prior t.o the experiment or during the interval between Bs and B,. SUBJECI 1 2 3 4 5 B0 I BI 0.4 2.7 0.9 1.5 0.5 0.7 0.4 1.9 0.03 1.6 B1 B: B* * 3.5 4.8 0.3 1.9 4.0 0.2 1.3 4.2 0.6 2.8 3.9 0.7 2.1 j 3.6 0.5 time yielded a straight line indicating that caffeine disappears at a rate propor- tional to its plasma concentration (fig. 1, typical esamples). Since negligible amounts of caffeine are excreted in urine and the drug is not localized in tissues, this decline reflects its rate of biotransformation. The biologic half-life, that is the time required for the plasma level to fall to half its value, was found to be fairly uniform from subject to subject, averaging 3.5 hours and ranging from 2.5 to 4.5 hours (12 to 22 per cent disappearance per hour). Biotransformation qf caj'eine in dogs. Plasma levels and urinary excretion of caffeine were studied in dogs following the intravenous administration of 4 FATE OF CAFFEINE IN MAN 523 mgm. per kgm. of the drug. In this species also the drug was almost entirely metabolized, little or none being excreted in the urine. The biologic half-life in the dog averaged 5 hours, a value about the same as that found for man. Accumulation of cage&e after repeated coffee drinking. In view of the wide- spread consumption of coffee it was of interest to determine whether caffeine accumulates in the body after the repeated drinking of coffee. Plasma levels of caffeine mere measured in five human subjects who has consumed eight cups of coffee' over a period of seven hours. It is apparent that after t,he repeated intake of coffee considerable amounts of caffeine accumulate in the body (t,able 3). The total amount of caffeine in the body may be calculated by multiplying the total body water by the concentration of drug in plasma water, since it has been shown (vide supra) that caffeine is approximately evenly distributed in body water. Assuming a total body water content of 55 per cent (Soberman et al., 1950) it can be estimated that about 180 mgm. of the drug were present in the body one hour after the last cup of coffee. This amount of caffeine is approximately equivalent to a therapeutic dose of the drug. There was no day to day accumula- tion of caffeine, as shown by the virtual disappearance of t,he drug by the follow- ing morning. SUMMARY A sensitive method for the estimation of caffeine in biological material is described. The method is specific in that it does not include transformation products of caffeine in the measurement. Caffeine is rapidly and essentially completely absorbed from the gastro- intestinal tract of man. Caffeine is almost entirely transformed in man, only about 1 per cent being excreted in the urine. The rate of biotransformation is fairly uniform from subject to subject, the average half-life being 3.5 hours (15 per cent metabolized per hour). The metabolic rate of transformation in dogs is about the same as in man. Caffeine is distributed in various tissues in approximate proportion to their water content. The drug passes rapidly into the central nervous system. Although a considerable amount of caffeine accumulates :n the body of moder- ately heavy coffee drinkers during the day, there is no day to day accumulation of the drug. AcknowEedgment. The authors wish to thank Dr. Victor McKusick for the administration of caffeine to the human subjects. REFERENCES BRODIE, B. B., UDENFRIEND, S., AND BAER, J.%.: J. Biol. Chem.,168:299,1947. FISHER, R. S., -4LGER1, E. J., AND WALKER, J. T.:J, Biol. Chem., 179: 71, 1949. ISIILER, H. H., FISWAKE, T. P., .kxn BORKER, E.: Anal. Chem., 20: 1162,1918. KIJSZ, A. F.: Biochem. Z., 276: 270, 1935. SOBERXAN,R.,BRODIE, B.B., LEVY, B., AXELROD, J., HOLLANDER,V.,ANDSTEELE, J.M.: J. Biol. Chem., 179: X,1949. ' TANAKE, U., AND OIIKCRO, Y.: J: Coll. Agr., Tokyo Imp. Univ., 14: 153, 1937. ' Go!uble coffee was used in these experiments. Each cup of coffee contained about SO mgm. of caffeine.